Borealis Biosciences was founded on the premise that a convergence of scientific and translational breakthroughs is enabling the field of RNA medicines to treat kidney diseases and beyond. The company is backed by founding investor Versant Ventures and Novartis AG, and has a strategic collaboration with the pharma.
Borealis Biosciences Address
null, null United States
Borealis Biosciences Email
Past Companies
Chinook Therapeutics, Inc.Director, Translational Medicine
PfizerAssociate Research Fellow
Ionis Pharmaceuticals, Inc.Director, Kidney Disease Drug Discovery